Home|
Pfizer Osteoporosis Drug Benefits Outweigh Risks, FDA Panel Says - Wall Street Journal Pfizer Osteoporosis Drug Benefits Outweigh Risks, FDA Panel SaysWall Street Journal - 1 hour agoBy JARED A. FAVOLE ROCKVILLE, Md. -- A panel of medical experts on Monday said the benefits of Pfizer Inc.'s proposed osteoporosis drug, Fablyn, outweigh the risks.UPDATE 1-U Home > Rss Directory > General > Google News |
|
FDA Issues Health Advisory On Pfizer's Chantix Tablets - Wall Street Journal Dog Flu Diet and DiseasesFDA Issues Health Advisory On Pfizer's Chantix TabletsWall Street Journal - 6 hours agoBy JENNIFER CORBETT DOOREN WASHINGTON -- The Food and Drug Administration said it is "increasingly likely" that Pfizer Inc.'s smoking-cessation drug Chantix Home > Rss Directory > General > Google News |
|
UPDATE 1-Study cites Pfizer smoking drug risk, shares fall - Reuters UPDATE 1-Study cites Pfizer smoking drug risk, shares fallReuters - 1 hour agoBy Susan Heavey WASHINGTON, May 21 (Reuters) - Hundreds of patients taking Pfizer Inc's (PFE.N: Quote, Profile, Research) anti-smoking drug Chantix have reported serious accidents, vision problems Home > Rss Directory > General > Google News |
|
Pfizer Tells Panel That Suicide Risks - Wall Street Journal Canada.comPfizer Tells Panel That Suicide RisksWall Street Journal - 2 hours agoBy JARED A. FAVOLE WASHINGTON -- Drug giant Pfizer Inc. on Thursday defended its epilepsy drugs, telling federal regulators and medical experts the drugs minimally increase the risk of suici Home > Rss Directory > General > Google News |
|
Pfizer Profit Beats Forecasts Pfizer Inc. said Wednesday that its fourth-quarter profit fell 70 percent from results a year ago that included gains on the sale of its consumer health business. Home > Rss Directory > Business > NY Time |
|
Pfizer to End Lipitor Ads by Jarvik Criticized that its ads are misleading, Pfizer said it would end a campaign using the artificial heart pioneer Robert Jarvik as a spokesman for its cholesterol drug Lipitor. Home > Rss Directory > Business > NY Time |
|
Pfizer Warns of Inhaled Insulin Lung Cancer Risk Pfizer and Nektar Therapeutics said clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to abandon the troubled product. Home > Rss Directory > Business > NY Time |
|
Pfizer Profit Drops by 18% Pfizer reported a worse-than-expected drop in quarterly earnings on Thursday. Home > Rss Directory > Business > NY Time |
|
Pfizer Begins Settling Painkiller Cases Pfizer has begun negotiating settlements with individual plaintiff’s firms over its Celebrex and Bextra painkillers, a New York lawyer said. Home > Rss Directory > Business > NY Time |
|
International Sales Lift Pfizer Profit Pfizer beat Wall Street expectations, saying its profit more than doubled as restructuring charges declined and the weak dollar helped lift overseas revenue. Home > Rss Directory > Business > NY Time |
|
Pfizer Acquires Rights to Alzheimer’s Drug Pfizer said that it was acquiring the rights to Dimebon, a promising experimental drug for Alzheimer’s disease, from Medivation for as much as $725 million. Home > Rss Directory > Business > NY Time |
|
Why Pfizer Made an Interesting Blockbuster Bet Pfizer inks a rich deal to get a late-stage-drug candidate. Home > Rss Directory > General > Motley Fool |
|
Pfizer sees opportunity in stem cells - Reuters eFluxMediaPfizer sees opportunity in stem cellsReuters - 38 minutes agoBy Julie Steenhuysen MADISON, Wisconsin (Reuters) - Stem cell research has long been the domain of tiny biotechnology companies operating on a shoestring budget, but new technologies allowing researc Home > Rss Directory > General > Google News |
|
New Windows Server will lead march to 64-bit OS The launch of a new family of Windows server products this week will kick-start a broad shift among customers to 64-bit versions of Microsoft's server software, analysts and customers said.Microsoft CEO Steve Ba Home > Rss Directory > Technology > InfoWorld |
|
Gates: Next decade will bring huge software advances The coming decade will bring even more advances in software and computing than the last 10 years, bringing new ways to watch television, to use telephones and to input information into computers, Microsoft chairman Bill Gates predicted Thursday. Home > Rss Directory > Technology > InfoWorld |
|
AMD's Fusion chip will be based on Phenom processor Advanced Micro Devices gave further details of its upcoming Fusion processor, saying it will be based on the design of a microprocessor used in the desktops currently shipping to enthusiast PC users such as gamers. Home > Rss Directory > Technology > InfoWorld |
|
WiMax will take flight with Intel's new mobile platform More than one-third of the ultramobile PCs coming later this year on Intel's Atom Centrino platform will offer a combination of WiMax and Wi-Fi, the head of the company's Ultra Mobility Group said Tuesday.Intel Home > Rss Directory > Technology > InfoWorld |
|
Feds: We will meet June IPv6 deadline U.S. federal government officials are confident they will meet a June 30 deadline to support IPv6 on their backbone networks, but they see challenges ahead in transitioning their production networks to this long-anticipated upgrade to the Internet's main communication Home > Rss Directory > Technology > InfoWorld |
|
Apple hopes cheaper iPhone 3G will broaden market As the iPhone 3G hits stores this week, Apple is aiming to gain more users by offering it at reduced prices through carriers.Apple has slashed the iPhone's price nearly in half, possibly attracting new buyers wh Home > Rss Directory > Technology > InfoWorld |
|
Gartner: Security through the cloud will triple by 2013 Security applications delivered as cloud-based services will more than triple by 2013, according to Gartner.The firm said 20 percent of the revenue of messaging security tools, such as antimalware and antispam s Home > Rss Directory > Technology > InfoWorld |